These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24712885)

  • 1. NMR-based approaches for the identification and optimization of inhibitors of protein-protein interactions.
    Barile E; Pellecchia M
    Chem Rev; 2014 May; 114(9):4749-63. PubMed ID: 24712885
    [No Abstract]   [Full Text] [Related]  

  • 2. NMR studies of ligand binding.
    Nitsche C; Otting G
    Curr Opin Struct Biol; 2018 Feb; 48():16-22. PubMed ID: 29017071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR by ILOEs: an NMR-based approach to reverse chemical genetics.
    Becattini B; Pellecchia M
    Chemistry; 2006 Mar; 12(10):2658-62. PubMed ID: 16121405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery.
    Moore JM
    Biopolymers; 1999; 51(3):221-43. PubMed ID: 10516573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyzing protein-ligand interactions by dynamic NMR spectroscopy.
    Mittermaier A; Meneses E
    Methods Mol Biol; 2013; 1008():243-66. PubMed ID: 23729255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR screening in drug discovery.
    Moore JM
    Curr Opin Biotechnol; 1999 Feb; 10(1):54-8. PubMed ID: 10047510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spin-lattice relaxation time in drug discovery and design.
    Figueroa-Villar JD; Tinoco LW
    Curr Top Med Chem; 2009; 9(9):811-23. PubMed ID: 19754396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies and methods in the identification of antagonists of protein-protein interactions.
    Gadek TR
    Biotechniques; 2003 Jun; Suppl():21-4. PubMed ID: 12813901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixture-Based Screening of Focused Combinatorial Libraries by NMR: Application to the Antiapoptotic Protein hMcl-1.
    Alboreggia G; Udompholkul P; Baggio C; Pellecchia M
    J Med Chem; 2023 Jul; 66(14):10108-10118. PubMed ID: 37464766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical aspects of NMR-based fragment discovery.
    Zartler ER; Mo H
    Curr Top Med Chem; 2007; 7(16):1592-9. PubMed ID: 17979770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry for fragment screening.
    Chan DS; Whitehouse AJ; Coyne AG; Abell C
    Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competition STD NMR for the detection of high-affinity ligands and NMR-based screening.
    Wang YS; Liu D; Wyss DF
    Magn Reson Chem; 2004 Jun; 42(6):485-9. PubMed ID: 15137040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR-based structural characterization of large protein-ligand interactions.
    Pellecchia M; Meininger D; Dong Q; Chang E; Jack R; Sem DS
    J Biomol NMR; 2002 Feb; 22(2):165-73. PubMed ID: 11883777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR for the design of functional mimetics of protein-protein interactions: one key is in the building of bridges.
    Song J; Ni F
    Biochem Cell Biol; 1998; 76(2-3):177-88. PubMed ID: 9923687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of protein-ligand interactions by NMR.
    Clarkson J; Campbell ID
    Biochem Soc Trans; 2003 Oct; 31(Pt 5):1006-9. PubMed ID: 14505469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranking of high-affinity ligands by NMR spectroscopy.
    Zhang X; Sänger A; Hemmig R; Jahnke W
    Angew Chem Int Ed Engl; 2009; 48(36):6691-4. PubMed ID: 19650100
    [No Abstract]   [Full Text] [Related]  

  • 18. Target-specific NMR detection of protein-ligand interactions with antibody-relayed
    Hetényi A; Hegedűs Z; Fajka-Boja R; Monostori É; Kövér KE; Martinek TA
    J Biomol NMR; 2016 Dec; 66(4):227-232. PubMed ID: 27885546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR approaches in structure-based lead discovery: recent developments and new frontiers for targeting multi-protein complexes.
    Dias DM; Ciulli A
    Prog Biophys Mol Biol; 2014; 116(2-3):101-12. PubMed ID: 25175337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental free ligand conformations: a missing link in structure-based drug discovery.
    Chiarparin E; Packer MJ; Wilson DM
    Future Med Chem; 2019 Jan; 11(2):79-82. PubMed ID: 30648432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.